Macrogenics reported $-50191000 in EBITDA for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Ebitda Change
Amgen AMGN:US $ 3228M 40M
AstraZeneca AZN:LN 2784M 588M
Biogen BIIB:US $ 991.8M 155.8M
Bristol Myers Squibb BMY:US $ 5712M 33M
Cerulean Pharma CERU:US $ -12.66M 3.51M
Daiichi Sankyo 4568:JP Y 53261M 7192M
Dicerna Pharmaceuticals DRNA:US $ -18.82M 19.76M
Eli Lilly And LLY:US $ 2437.5M 639.8M
Epizyme EPZM:US $ -62.82M 6.9M
Geron GERN:US $ -25.62M 3.22M
Gilead Sciences GILD:US $ 4370M 1605M
Johnson & Johnson JNJ:US $ 8192M 2043M
Karyopharm Therapeutics KPTI:US $ -43626000 5.19M
Macrogenics MGNX:US $ -50191000 12.69M
Mirati Therapeutics MRTX:US $ -78.98M 84.79M
Pfizer PFE:US $ 10235M 2245M
Puma Biotechnology PBYI:US $ -6.51M 7.18M
Regeneron Pharmaceuticals REGN:US $ 1920.4M 1497.9M
Seattle Genetics SGEN:US $ -281.36M 207.58M
Xencor XNCR:US $ -39.31M 50.15M